首页 > 快讯 > 正文

Telink Pharmaceutical (01011.HK) rose by 250%. The company announced that it is considering issuing letter shares to four creditors to capitalize the outstanding principal amount and interest of the existing loans owed by the group to subscribers.

clock
2024-10-10 09:22:53
Telink Pharmaceutical (01011.HK) rose by 250%. The company announced that it is considering issuing letter shares to four creditors to capitalize the outstanding principal amount and interest of the existing loans owed by the group to subscribers.